OUR STORY
Trusted Innovation in Cannabis-Derived APIs At MMC Laboratories, we are driving innovation in the pharmaceutical cannabis sector by delivering high-quality, cannabis-derived active pharmaceutical ingredients (APIs) for the global market.
Founded in September 2022 and based in Lilongwe, Malawi, MMC Laboratories was established in response to the rising international demand for reliable, medically beneficial cannabis products. Backed by an experienced leadership team in the cannabis and pharmaceutical industries, we are committed to being the trusted partner in the production of quality cannabis APIs.
OUR MISSION
To better mankind by producing to the highest quality cannabinoid compounds in the world.
01
OUR VISION
To become a leading, globally recognised API producer, renowned for its commitment to compliance, ethics, and regulation. We aspire to contribute to MW2063 vision, through innovative agricultural practices, commercialisation, and sustainable industrial development.
02
LEADERSHIP TEAM
At MMC Laboratories, our strength lies in the collective experience of our leadership team.
03
Our Areas of focus
Our core areas of focus include:
At MMC Laboratories, we are dedicated to advancing the cannabis industry through innovation, compliance, and sustainable practices.
1. Pharmaceutical-Grade Cannabis APIs
We specialise in the extraction and production of high-quality Active Pharmaceutical Ingredients (APIs) derived from cannabis, including CBD, cannabis flos, terpenes, and rare cannabinoids. Our processes adhere to EU Good Manufacturing Practice (GMP) standards, ensuring products meet international pharmaceutical quality requirements.
2. EU-Compliant Cultivation & Processing
Our vertically integrated operations encompass GACP-compliant cultivation across 12 hectares and GMP-grade processing within a 1,000 sqm pharmaceutical facility. This includes Grade D cleanrooms, CO₂ extraction, and critical fluid chromatography, enabling us to maintain strict quality control from seed to final product.
3. Export-Ready Supply Chains
Positioned to serve global pharmaceutical and wellness markets, our facility is designed for the export of compliant cannabis products. With a capacity to deliver 600 kg of API output per month, we contribute to Malawi's emergence as a competitive player in international cannabis trade.
4. Research, Innovation & Quality Systems
We prioritise compliance and innovation through a Pharmaceutical Quality System (PQS) aligned with International Council for Harmonisation (ICH) guidelines. Our commitment to continuous improvement ensures that we remain at the forefront of cannabis research and development.
5. Sustainable & Inclusive Economic Growth
MMC Laboratories supports local farmers by providing structured market access, contract farming opportunities, and integration into a regulated, high-value supply chain. This approach fosters job creation, skill development, and sustainable economic growth within Malawi's agro-industrial sector.
6. Malawi 2063 Goals
Our projects are in line with the Malawi 2063 goals.
Frequently Asked Questions
Get to know what is driving MMC Laboratories innovation in the pharmaceutical cannabis sector while delivering high-quality, cannabis-derived active pharmaceutical ingredients (APIs) for the global market.
